Asthma Drugmaker Choking on FDA Form 483 Observations
Links shared publicly online about this topic.
- 33total visits
Asthma Drugmaker Choking on FDA Form 483 Observations
Nephron Pharmaceuticals, a Fla.-based drugmaker, was handed a Form 483 after an FDA inspection found it failed to fully review unexplained discrepancies or failures of batches of albuterol sulfate solution to meet specifications.
View full resource at fdanews.com
Most Recently Shared on January 21, 2012 at 10:47 pm By:
Asthma Drugmaker Choking on FDA Form 483 Observations http://t.co/Li8UNALw
Advertisement
